Dragon's Blood (Sangre De Grado)
Dragon's blood is the red latex of Croton lechleri; human studies mainly test the purified extract crofelemer for diarrhea.
We evaluated 21 human studies on Dragon's blood (sangre de grado), including 3 randomised controlled trials and 0 meta-analyses or systematic reviews; the controlled studies include 240 participants in total. As of 3 October 2026.
1. What Is Dragon's Blood (Sangre De Grado)? Occurrence, Origin and Forms
Dragon's blood, Spanish sangre de grado, is the red latex of the South American tree Croton lechleri of the spurge family. It contains mainly proanthocyanidins and the alkaloid taspine; the drug crofelemer is also obtained from it.
The tree grows in the western Amazon region, for example in Peru and Ecuador. The latex flows when the bark is cut and is traditionally applied to wounds and taken for diarrhoea.
Products include the liquid latex for topical or oral use, as well as creams and dental care products. Crofelemer is a purified extract of the latex approved as a medicine for diarrhoea.
Forms and Preparations Studied
- Liquid latex (sangre de grado) applied to the skin
- Latex taken by mouth
- Crofelemer, the purified extract of the latex
- Creams and dental products with dragon's blood
Not covered on this page:
- Dragon's blood resins from other plants (Dracaena, Daemonorops, Pterocarpus)
2. What Does Dragon's Blood (Sangre De Grado) Do? Results by Area
| Area | Result in controlled studies | Strength of evidence | Studies | Participants |
|---|---|---|---|---|
| Diarrhoea and digestion | mostly improved | moderate | 0 meta-analyses · 4 controlled · 13 other | 240 |
| Skin and wounds | mostly improved | low | 0 meta-analyses · 1 controlled · 2 other | 0 |
| Other outcomes | mostly no difference | unclear | 0 meta-analyses · 1 controlled · 2 other | 0 |
How to read the table: counted are human studies whose results concern the area. “High” means at least one meta-analysis and two controlled studies showing improvement, or at least three controlled studies of which three quarters show improvement, with at least 300 participants in total. “Moderate” means at least two controlled studies showing improvement, as a majority, or one meta-analysis alongside controlled studies. “Low” means one controlled study showing improvement. Where an area has no controlled study, the strength of evidence is at most “low” (result “reviews only” or “observational data only”). Everything else is “unclear”. A study counts as showing improvement when at least half of its outcomes in this area improved. Reviews of combination products do not count as meta-analyses; results that only describe side effects or shares of users do not count as an effect. The same study is counted only once.
3. What the Studies Show in Detail
Dragon's Blood (Sangre De Grado), Diarrhoea and Digestion: Human Studies
For diarrhea and digestion, mainly crofelemer was studied, the purified extract from the latex of Croton lechleri. The finding was clearest in HIV-positive people with chronic noninfectious diarrhea 3. There, in a randomized controlled trial, more patients responded on crofelemer than on placebo, with fewer watery stools and firmer stool 3. In diarrhea during chemotherapy for breast cancer, an open-label randomized trial missed its primary endpoint 2. However, at least moderate diarrhea occurred less often there and resolved more frequently than in the control group 2. In women with diarrhea-predominant irritable bowel syndrome, a randomized controlled trial missed its primary endpoint, pain-free days 1. In a post-hoc analysis, however, abdominal pain responded more frequently than with placebo, stool consistency did not 1. A small controlled, non-randomized trial suggests an effect of crofelemer in diarrhea during neratinib 4. For the raw sap for ingestion, only one review is available, which reports positive clinical findings in travelers' diarrhea and watery diarrhea 19.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 1 Nee et al. 2019 | randomised controlled · 240 participants | Crofelemer, purified extract from Croton lechleri latex; 125 mg twice daily; 12 weeks; vs. Placebo | Percentage of pain/discomfort-free days (primary endpoint): no difference; FDA abdominal pain monthly responders, months 1-2: improved (58.3% vs 45.0%, P = 0.030); FDA abdominal pain monthly responders, entire 3 months: improved (54.2% vs 42.5%, P = 0.037) |
| 2 Pohlmann et al. 2022 | randomised controlled | crofelemer 125 mg orally; 125 mg twice daily; chemotherapy cycles 1 and 2; vs. no scheduled prophylactic medication (control), both with breakthrough antidiarrheal medication | incidence of any-grade CID for ≥2 consecutive days: no difference; incidence of grade ≥2 CID, cycle 1: improved (19.2% vs 24.0%); incidence of grade ≥2 CID, cycle 2: improved (8.0% vs 39.1%) |
| 3 Macarthur et al. 2013 | randomised controlled | Crofelemer (purified dragon's blood extract); 125 mg, 250 mg or 500 mg twice daily; stage II: 125 mg twice daily; 4 weeks placebo-controlled, then 20-week open-label extension; vs. Placebo | Clinical response (≤2 watery stools/week during ≥2 of 4 weeks): improved (17.6% vs 8.0%; one-sided, P = .01); Change from baseline in daily watery bowel movements: improved (P = .04); Change from baseline in daily stool consistency score: improved (P = .02) |
| 4 Jacob et al. 2023 | controlled | Crofelemer; 125 mg twice daily; first 2 cycles prophylactic, then as needed; vs. Dose-escalated neratinib with loperamide as needed | Incidence of grade 3 diarrhea in first 2 cycles: improved (2 patients (29%)); Diarrhea controlled with crofelemer alone: improved (Five of 7 patients); Diarrhea episodes per day: unclear (0.58) |
| 6 Greene et al. 2021 | case report | crofelemer (off-label); vs. no comparator (case report) | TKI-induced diarrhea: improved (successfully controlled the treatment-related diarrhea) |
| 7 QUART et al. 2008 | study | Polymeric proanthocyanidin composition from Croton or Calophyllum species, e.g. crofelemer | Prevention of colon cancer: unclear; Treatment of intestinal inflammation: unclear; Treatment of intestinal pain: unclear |
| 8 Frampton et al. 2013 | review · 376 participants | Crofelemer (Fulyzaq), oligomeric proanthocyanidin from Croton lechleri latex; 125 mg twice daily orally; 4 weeks placebo-controlled, 5-month open-label extension; vs. Placebo | Secretory diarrhoea: improved (significantly reduced) |
| 9 Amin et al. 2026 | review | Crofelemer, oral plant-derived botanical drug | efficacy in chronic noninfectious diarrhea: unclear |
Further studies in this area: 11 12 13 14 15 16 17 18 19
Dragon's Blood (Sangre De Grado), Skin and Wounds: Human Studies
A review on dermatology mentions clinical studies that point to wound-healing and antiviral properties of dragon's blood 10. Another review mentions relief of itching, pain and swelling from insect bites by the sap 19. A controlled, non-randomized trial tested a cream with pomegranate seed oil and resin extract of Croton lechleri for stretch marks 5. Dermis thickness, skin moisture and elasticity increased in both groups 5. The share of dragon's blood cannot be determined from this. It remains open whether the pure latex or crofelemer actually improve skin and wound healing in humans.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 5 Bogdan et al. 2017 | controlled | O/W cream with pomegranate seed oil and C. lechleri resin extract; 6 weeks; vs. two groups, nonrandomized | dermis thickness: improved; skin hydration: improved; skin elasticity: improved |
| 10 Pona et al. 2019 | review | Dragon's Blood from Croton lechleri | Wound healing: improved; Antiviral properties: improved |
| 19 Jones et al. 2003 | review | Sangre de Grado (sap of Croton lechleri) | symptoms of insect bites (itching, pain, swelling): improved (positive results) |
Dragon's Blood (Sangre De Grado): Further Outcomes in Studies
In HIV-positive patients with chronic diarrhea, crofelemer did not impair clinical immune parameters in a randomized controlled trial 3. A review reports that HIV viral load and CD4 cell count remained unchanged 8. Only crofelemer was studied, the purified extract from the latex of Croton lechleri, not the raw sap; controlled data on immune parameters and safety markers of the raw latex are lacking.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 3 Macarthur et al. 2013 | randomised controlled | Crofelemer (purified dragon's blood extract); 125 mg, 250 mg or 500 mg twice daily; stage II: 125 mg twice daily; 4 weeks placebo-controlled, then 20-week open-label extension; vs. Placebo | Clinical immune parameters: no difference |
| 8 Frampton et al. 2013 | review · 376 participants | Crofelemer (Fulyzaq), oligomeric proanthocyanidin from Croton lechleri latex; 125 mg twice daily orally; 4 weeks placebo-controlled, 5-month open-label extension; vs. Placebo | HIV viral load and CD4+ cell counts: no difference (no appreciable effect) |
| 17 2012 | review | Crofelemer | serum enzyme elevations: unclear; clinically apparent acute liver injury: no difference |
4. How Is Dragon's Blood (Sangre De Grado) Dosed? Preparation, Dose and Duration in Studies
The controlled trials used almost exclusively crofelemer, the purified extract from the latex of Croton lechleri, orally for diarrhea 1234. For the liquid sap for application, the sap for ingestion, and for creams and dental care products with dragon's blood, only reviews or one non-randomized trial of a combination product are available in human studies 51019.
| Preparation or form | Dose | Duration | Study |
|---|---|---|---|
| Crofelemer, purified extract from Croton lechleri latex | 125 mg twice daily | 12 weeks | 1 |
| crofelemer 125 mg orally | 125 mg twice daily | chemotherapy cycles 1 and 2 | 2 |
| Crofelemer (purified dragon's blood extract) | 125 mg, 250 mg or 500 mg twice daily; stage II: 125 mg twice daily | 4 weeks placebo-controlled, then 20-week open-label extension | 3 |
| Crofelemer | 125 mg twice daily | first 2 cycles prophylactic, then as needed | 4 |
| O/W cream with pomegranate seed oil and C. lechleri resin extract | — | 6 weeks | 5 |
5. Is Dragon's Blood (Sangre De Grado) Safe? Side Effects in Studies
Crofelemer was well tolerated in the trials, with a safety profile similar to placebo 13818. It is hardly absorbed from the intestine 38131415. In a small controlled, non-randomized trial, most treated participants developed constipation, consistently mild 4. Reviews mention occasional serum enzyme elevations without clinically manifest acute liver injury as well as mild gastrointestinal effects 1617. Crofelemer was also well tolerated in an open-label safety study lasting nearly one year 8.
| Study | Reported side effects |
|---|---|
| 1 Nee et al. 2019 | Safety profile similar to placebo |
| 3 Macarthur et al. 2013 | Minimally absorbed, well tolerated, safety profile comparable to placebo |
| 4 Jacob et al. 2023 | 82% constipation, all grade 1 |
| 8 Frampton et al. 2013 | Infections and GI disorders most frequent; overall incidence similar to placebo |
| 9 Amin et al. 2026 | Safety and tolerability discussed, no numbers given |
| 13 Patel et al. 2013 | minimal adverse events, well tolerated, not systemically absorbed |
| 14 Yeo et al. 2013 | not absorbed, well tolerated in small trials; long-term safety lacking |
| 15 Chordia et al. 2013 | well tolerated, minimal systemic absorption, good safety profile |
| 16 Cottreau et al. 2012 | minimal toxicity beyond mild gastrointestinal effects |
| 17 2012 | occasional serum enzyme elevations; no clinically apparent acute liver injury |
| 18 Crutchley et al. 2010 | Oral crofelemer well tolerated, adverse effect profile comparable to placebo |
| 19 Jones et al. 2003 | low toxicity, well tolerated in clinical studies |
6. What Remains Open: Limits of the Evidence
- Most controlled trials tested crofelemer, not the raw latex; their results cannot be transferred to the sap for application or ingestion.
- For skin and wounds, randomized controlled trials are lacking; the available trial involved a combination product without randomization.
- Controlled data on immune parameters and safety markers of the raw latex are lacking.
- The study populations are narrowly defined (irritable bowel syndrome, HIV-associated diarrhea, cancer therapy-associated diarrhea), which limits transferability.
- Information on manufacturer funding of the trials is lacking, which complicates the assessment of the results.
7. Bottom Line: What Is Established About Dragon's Blood (Sangre De Grado)
Dragon's blood, the red latex of Croton lechleri, is studied in human trials almost exclusively in the form of the purified extract crofelemer for diarrhea. The benefit over placebo is clearest in HIV-associated diarrhea 3. In irritable bowel syndrome and chemotherapy-induced diarrhea, randomized trials missed their primary endpoint but showed benefits in secondary analyses 12. Tolerability was good in the trials, with a profile similar to placebo 13818.
Frequently Asked Questions
How well has Dragon's blood (sangre de grado) been studied in humans?
We evaluated 21 human studies on Dragon's blood (sangre de grado), including 3 randomised controlled trials and 0 meta-analyses or systematic reviews; the controlled studies include 240 participants in total. As of 3 October 2026.
Does Dragon's blood (sangre de grado) help with diarrhoea and digestion? What the studies show
Does Dragon's blood (sangre de grado) help with skin and wounds? What the studies show
What is dragon's blood studied for in human trials?
The focus is on diarrhea and digestion, where mainly the purified extract crofelemer was tested 1234. The benefit over placebo was clearest in HIV-associated diarrhea 3. For the skin, reviews mention clinical evidence of wound healing and antiviral properties 10 as well as relief from insect bites 19. Randomized trials on skin and wounds are still pending.
Are there also results without a difference?
Yes. In women with diarrhea-predominant irritable bowel syndrome, pain-free days and stool consistency did not differ from placebo in a randomized controlled trial 1. In diarrhea during chemotherapy, an open-label randomized trial missed its primary endpoint, diarrhea of any severity 2. In HIV-positive patients, crofelemer did not impair clinical immune parameters in a randomized controlled trial 3.
How well is dragon's blood tolerated?
Sources
- 1Nee J, Salley K, Ludwig AG, Sommers T, Ballou S, Takazawa E et al. · 2019
- 2Pohlmann PR, Graham D, Wu T, Ottaviano Y, Mohebtash M, Kurian S et al. · 2022
- 3Macarthur RD, Hawkins TN, Brown SJ, Lamarca A, Clay PG, Barrett AC et al. · 2013
- 4Jacob S, Johnson M, Roque B, Quintal L, Rugo HS, Melisko M et al. · 2023
- 5
- 6Greene C, Barlesi B, Tarroza-David S, Friedlander T · 2021
- 7Compositions and Methods for Treating or Preventing Inflammatory Bowel Disease, Familial Adenomatous Polyposis and Colon CancerQUART BARRY D · 2008
- 8
- 9Amin A, Haneef A, Altaf S, Rasny MRM · 2026
- 10Pona A, Cline A, Kolli SS, Taylor SL, Feldman SR · 2019
- 11Castro JG, Chin-Beckford N · 2015
- 12
- 13Patel TS, Crutchley RD, Tucker AM, Cottreau J, Garey KW · 2013
- 14Yeo QM, Crutchley R, Cottreau J, Tucker A, Garey KW · 2013
- 15Chordia P, MacArthur RD · 2013
- 16Cottreau J, Tucker A, Crutchley R, Garey KW · 2012
- 17Crofelemer· 2012
- 18Crutchley RD, Miller J, Garey KW · 2010
- 19
Every statement on this page carries its evidence tier — proven, plausible or hypothesis — and leads to the original work. The decision in the individual case rests with the practitioner; we provide the connections.